The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.

被引:0
|
作者
La-Beck, N. M.
Wu, H.
Infante, J. R.
Jones, S. F.
Burris, H. A., III
Keedy, V. L.
Kodaira, H.
Ikeda, S.
Ramanathan, R. K.
Zamboni, W.
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Yakult Honsha, Tokyo, Japan
[8] Virginia G Piper Canc Ctr & TGen, Scottsdale, AZ USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13003
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Liposomal anticancer drugs as agents to be used in combination with other anticancer agents: Studies on a liposomal formulation with two encapsulated drugs
    Saxon, DN
    Mayer, LD
    Bally, MB
    JOURNAL OF LIPOSOME RESEARCH, 1999, 9 (04) : 507 - 522
  • [32] Multiple injections of pegylated liposomal doxorubicin: Pharmacokinetics and therapeutic activity
    Charrois, GJR
    Allen, TM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 1058 - 1067
  • [33] Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
    Gabizon, A
    Shmeeda, H
    Barenholz, Y
    CLINICAL PHARMACOKINETICS, 2003, 42 (05) : 419 - 436
  • [34] Preclinical evaluation of the efficacy of STI571 in combination with a variety of novel anticancer agents.
    La Rosée, P
    Johnson, K
    Moseson, EM
    O'Dwyer, M
    Druker, BJ
    BLOOD, 2001, 98 (11) : 839A - 839A
  • [35] Liposomal, nanoparticle, and conjugated formulations of anticancer agents
    Zamboni, WC
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8230 - 8234
  • [36] Conformational analysis of naturally occurring enediyne anticancer agents.
    Splain, R
    Parish, CA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U332 - U332
  • [37] Bile acids affect chemosensitivity of tumors to anticancer agents.
    Sakamoto, Y
    Nakashima, T
    Nakajima, Y
    Ishikawa, H
    Mitsuyoshi, H
    Inaba, K
    Okanoue, T
    Kashima, K
    HEPATOLOGY, 1997, 26 (04) : 90 - 90
  • [38] Platinum anticancer agents. Structures and targeted biomolecules.
    Farrell, NP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U728 - U728
  • [39] Polyamine-assisted delivery of anticancer and antimalarial agents.
    Phanstiel, O
    Chakrabarti, D
    Nemchik, A
    Pignon, P
    Dasilva, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A112 - A112
  • [40] Synthesis of analogs of ellagic acid as potential anticancer agents.
    Sun, H
    Kinstle, TH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 49 - MEDI